HEATHER GRIFFITH: Open Payments
NPI 1508205519 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 39 payments from 17 companies in 2025. Trend: 2023 $335 · 2024 $918 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $221 |
| Verona Pharma, Inc. | 3 | $63 |
| Exact Sciences Corporation | 4 | $61 |
| SHIELD THERAPEUTICS INC | 3 | $56 |
| Amgen Inc. | 3 | $48 |
| Abbott Laboratories | 2 | $45 |
| ABBVIE INC. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: Ozempic, Ohtuvayre, Cologuard Collection Kit, ACCRUFER, EVENITY, FREESTYLE LIBRE 3, JARDIANCE, QULIPTA.
Industry payments across PA — which companies pay providers there.
